GAMMA Investing’s TriSalus Life Sciences TLSI Stock Holding History

GAMMA Investing’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-386	Closed	-$1.54K	–	4229
2026 Q1	$1.54K	Buy	386 +328	+566%	+$1.61K	﹤0.01%	3738
2025 Q4	$405	Buy	+58	New	+$325	﹤0.01%	3934

Other funds holding TLSI

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

RDFA

Ritter Daniher Financial Advisory Cincinnati, Ohio $657M AUM 20.27% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's TLSI Position: Q2 2026 in Review

GAMMA Investing sold out of TriSalus Life Sciences (TLSI) in Q2 2026, closing a stake of 386 shares — an estimated $1.54K sold.

GAMMA Investing first reported a position in TLSI in Q4 2025 and held it in 2 quarters. The position peaked at $1.54K in Q1 2026. 4 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

GAMMA Investing reported no remaining TriSalus Life Sciences position as of Q2 2026 after selling out during the quarter.
GAMMA Investing sold 386 TriSalus Life Sciences shares in Q2 2026, an estimated $1.54K.
GAMMA Investing first reported a position in TriSalus Life Sciences in Q4 2025 and held it in 2 quarters.
GAMMA Investing's TriSalus Life Sciences position peaked at $1.54K in Q1 2026.
4 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.